Research Site

Eau Claire, Wisconsin 54703

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Carcinoma, Metastases, Neoplasm, Non-small Cell Lung Cancer (NSCLC), Non-small-cell Lung

Studies at this site

• Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations — Recruiting now
• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling
• Iressa Expanded Access Program (EAP) — Completed